An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease
Clinical trial NCT05899673 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05899673
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-08
- Primary completion
- 2033-05-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.